Nouvelles Eulerpool Nurexone Biologic

Eulerpool-AFX Nurexone Biologic

Nurexone Biologic Actualités des actions

Nurexone Biologic est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Nurexone Biologic.

• 29 juillet ·

  Yahoo
  NurExone Announces Further Expansion of ExoPTEN Patent Coverage
• 17 juillet ·

  Yahoo
  Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
• 17 juillet ·

  Yahoo
  Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
• 5 juillet ·

  Yahoo
  Updates from NurExone: Growth Conference Presentation and Website Relaunch
• 28 juin ·

  Yahoo
  NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
• 21 juin ·

  Yahoo
  On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
• 11 juin ·

  Yahoo
  NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
• 4 juin ·

  Yahoo
  NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
• 31 mai ·

  Yahoo
  Is NurExone Biologic (CVE:NRX) In A Good Position To Deliver On Growth Plans?
• 29 mai ·

  Yahoo
  NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials